Wednesday, November 30, 2016

acetazolamide

During case presentations, student presented that a patient was taking acetazolamide for hydrocephalus until she could get in for surgery, I was unaware of this use for it so needed to look into it more:

hydrocephalus: disorder of excessive amount of cerebrospinal fluid which accumulates in the ventricles and subarachnoid space
  • CSF is produced by the choroid plexus -- epithelium and connective tissue in cerebral ventricles
    • epithelial cells produce CSF using active transport which is dependent upon carbonic anhydrase
  • CSF production is generally constant unless intracranial pressure is increased (absorption matches the production)
  • production rate ~20mL/hour, complete turnover 3-4 time a day
  • hydrocephalus results from imbalance between inflow and outflow
    • obstruction of circulation
    • inadequate absorption
    • overproduction
  • leads to increased intracranial pressure and ventricular dilation
  • etiology: congenital, neural tube defects, CNS malformations, intrauterine infections, choroid plexus carcinoma, infections, tumors, post-hemorrhagic
  • symptoms: headache, N/V, personality/behavior changes, lethargy
    • bradycardia, hypertension, altered respiratory rate
    • macrocephaly
    • compression of cranial nerves
  • Progressive (need to manage or will get worse)
  • most effective treatment: surgical drainage using a ventriculostomy shunt (prevents excess accumulation of CSF, shunts CSF to either systemic circulation or peritoneum)
  • Medical therapy:
    • diuretics: furosemide and acetazolamide decrease CSF production
      • used for short periods in slowly progressive hydrocephalus that is too unstable for surgery or until surgery can be done
      • diuretics generally not effective for infants
  • acetazolamide can be used for: acute mountain sickness, edema, glaucoma, retinal edema,
  • need to dose adjust for renal impairment, caution in liver disease (can induce coma
  • Mechanism of action: inhibits carbonic anhydrase from catalyzing the reversible hydration of carbon dioxide and dehydration of carbonic acid
    • delays abnormal paroxysmal excessive discharge from CNS neurons and affects promotion of diuresis and urinary alkalinization
  • adverse effects: metabolic acidosis, stevens Johnson syndrome, hepatic necrosis, agranulocytosis, thrombocytopenia, angle-closure glaucoma
  • monitoring: CBC and electrolytes

No comments:

Post a Comment